Q&A with Mitchell Smith: The Merits of Ten Year Followup

DECEMBER 07, 2015
Amy Jacob


Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.
 
According to Smith, "While response rates aren't as high as we like, and they're not durable in everyone, you can see on the horizon advances in the cell technology and in patient selection."


Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.